DUAL ACTION

ACETAMINOPHEN AND IBUPROFEN (NSAID) TABLETS, 250 MG/125 MG · Dr. Reddy's Laboratories Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DUAL ACTION, covering 2023-07-10 to 2024-08-23. Get the full timeline:

Most recent: FDA Approved: DUAL ACTION — Original Application (Dr. Reddy's Laboratories Inc)